<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hoffmann A</submitter><funding>Deutsche Forschungsgemeinschaft (DFG)</funding><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Jürgen Manchot Stiftung</funding><funding>Open Access Publication Fund of the University of Bonn</funding><funding>Jürgen Manchot Stiftung (Jürgen Manchot Foundation)</funding><funding>Bundesministerium für Bildung und Forschung (BMBF)</funding><pagination>e0076423</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11237698</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(5)</volume><pubmed_abstract>Cervimycins A-D are bis-glycosylated polyketide antibiotics produced by &lt;i>Streptomyces tendae&lt;/i> HKI 0179 with bactericidal activity against Gram-positive bacteria. In this study, cervimycin C (CmC) treatment caused a spaghetti-like phenotype in &lt;i>Bacillus subtilis&lt;/i> 168, with elongated curved cells, which stayed joined after cell division, and exhibited a chromosome segregation defect, resulting in ghost cells without DNA. Electron microscopy of CmC-treated &lt;i>Staphylococcus aureus&lt;/i> (3 × MIC) revealed swollen cells, misshapen septa, cell wall thickening, and a rough cell wall surface. Incorporation tests in &lt;i>B. subtilis&lt;/i> indicated an effect on DNA biosynthesis at high cervimycin concentrations. Indeed, artificial downregulation of the DNA gyrase subunit B gene (&lt;i>gyrB&lt;/i>) i</pubmed_abstract><journal>mSphere</journal><pubmed_title>The unusual mode of action of the polyketide glycoside antibiotic cervimycin C.</pubmed_title><pmcid>PMC11237698</pmcid><funding_grant_id>398967434</funding_grant_id><funding_grant_id>03ZZ0808D</funding_grant_id><pubmed_authors>Sahl H-G</pubmed_authors><pubmed_authors>Bierbaum G</pubmed_authors><pubmed_authors>Nieselt K</pubmed_authors><pubmed_authors>Hertweck C</pubmed_authors><pubmed_authors>Franz-Wachtel M</pubmed_authors><pubmed_authors>Scherlach K</pubmed_authors><pubmed_authors>Hoffmann A</pubmed_authors><pubmed_authors>Steffens U</pubmed_authors><pubmed_authors>Macek B</pubmed_authors><pubmed_authors>Harbig TA</pubmed_authors></additional><is_claimable>false</is_claimable><name>The unusual mode of action of the polyketide glycoside antibiotic cervimycin C.</name><description>Cervimycins A-D are bis-glycosylated polyketide antibiotics produced by &lt;i>Streptomyces tendae&lt;/i> HKI 0179 with bactericidal activity against Gram-positive bacteria. In this study, cervimycin C (CmC) treatment caused a spaghetti-like phenotype in &lt;i>Bacillus subtilis&lt;/i> 168, with elongated curved cells, which stayed joined after cell division, and exhibited a chromosome segregation defect, resulting in ghost cells without DNA. Electron microscopy of CmC-treated &lt;i>Staphylococcus aureus&lt;/i> (3 × MIC) revealed swollen cells, misshapen septa, cell wall thickening, and a rough cell wall surface. Incorporation tests in &lt;i>B. subtilis&lt;/i> indicated an effect on DNA biosynthesis at high cervimycin concentrations. Indeed, artificial downregulation of the DNA gyrase subunit B gene (&lt;i>gyrB&lt;/i>) i</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 May</publication><modification>2026-04-29T12:08:33.841Z</modification><creation>2025-04-07T12:00:08.369Z</creation></dates><accession>S-EPMC11237698</accession><cross_references><pubmed>38722162</pubmed><doi>10.1128/msphere.00764-23</doi></cross_references></HashMap>